Skip to content
ClinCalc Pro
Menu
ophthalmology paediatrics

Refractive Error & Myopia Severity Classification

International Myopia Institute classification (IMI 2019): myopia is a spherical equivalent (SE) of −0.50 D or less, high myopia −6.00 D or less, using cycloplegic refraction in children. Pathologic myopia is defined by structural changes, not by refraction. Higher myopia confers greater lifetime risk of myopic maculopathy, retinal detachment, glaucoma, and cataract.

Score interpretation

Not Myopic 0

SE more positive than −0.50 D. In children, −0.50 to +0.75 D with risk factors is 'pre-myopia' (IMI 2019).

→ Children: cycloplegic refraction; treat amblyopia and accommodative esotropia with full correction if significantly hyperopic; encourage outdoor time if pre-myopic. Adults: spectacles/contact lenses if symptomatic; assess for asthenopia and angle closure risk in hyperopia.

Low Myopia 1

SE −0.50 D or less, but more positive than −6.00 D (IMI 2019).

→ Spectacles/contacts. In children: discuss myopia control (low-dose atropine eye drops — Children: use a children's formulary. dual-focus contact lenses, MiSight, orthokeratology) per IMI 2021; active myopia control if progressing. Outdoor time ≥2 h/day. Discuss lifetime retinal detachment risk.

High Myopia (≤ −6.00 D) 2

SE −6.00 D or less (IMI 2019).

→ Posterior segment surveillance (OCT macula + dilated peripheral retina) every 1–2 years. Counsel on symptoms of detachment (flashes/floaters/curtain). Look for posterior staphyloma / myopic maculopathy (pathologic myopia); treat myopic CNV (anti-VEGF — NICE TA298 ranibizumab). Refractive surgery options if stable; ICL preferred over LASIK above ~−10 D. Active myopia control in children.

Interpretation bands for the Myopia Severity. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.